High-level expression of human cytochrome P450 1A2 by co-expression with human molecular chaperone HDJ-1 (Hsp40)

被引:14
作者
Ahn, T [1 ]
Yang, SY
Yun, CH
机构
[1] Chonnam Natl Univ, Coll Vet Med, Dept Biochem, Kwangju 500757, South Korea
[2] Chonnam Natl Univ, Dept Mol Med, Kwangju 500757, South Korea
[3] Chonnam Natl Univ, Sch Biol Sci & Technol, Kwangju 500757, South Korea
关键词
molecular chaperone HDJ-1; human CYP1A2; CYP1A2; expression;
D O I
10.1016/j.pep.2004.03.005
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Human cytochrome P450 (CYP) 1A2 is of great interest because of its important roles in the oxidation of numerous drugs and carcinogens. HDJ-1, a molecular chaperone in human, is known to assist the correct folding of unfolded proteins. To achieve high yield of recombinant human CYP1A2 in Escherichia coli, the CYP1A2 encoding gene was co-expressed with the chaperone HDJ-1 under the control of an inducible tac promoter in bicistronic format. Expression level of CYP1A2 in the bicistronic construct reached up to 520 nmol/liter culture within 16 It at 37degreesC, which is 3.4-fold increase compared to the expression yield of CYP1A2 alone without HDJ-1. By co-expression with HDJ-1, the catalytic activity of CYP1A2 was also increased 5.5-fold. The activity increase seems to be associated with the increase of CYP production at whole cell level. The present over-expression system may be useful for rapid production of large amounts of active human CYP1A2 in E coli. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:48 / 52
页数:5
相关论文
共 20 条
[1]   Mammalian, yeast, bacterial, and chemical chaperones reduce aggregate formation and death in a cell model of oculopharyngeal muscular dystrophy [J].
Bao, YP ;
Cook, LJ ;
O'Donovan, D ;
Uyama, E ;
Rubinsztein, DC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (14) :12263-12269
[2]  
BURKE MD, 1983, CHEM-BIOL INTERACT, V45, P243
[3]   HUMAN CYTOCHROME P-450PA (P-450IA2), THE PHENACETIN O-DEETHYLASE, IS PRIMARILY RESPONSIBLE FOR THE HEPATIC 3-DEMETHYLATION OF CAFFEINE AND N-OXIDATION OF CARCINOGENIC ARYLAMINES - (AROMATIC-AMINES HETEROCYCLIC AMINES CARCINOGEN METABOLISM) [J].
BUTLER, MA ;
IWASAKI, M ;
GUENGERICH, FP ;
KADLUBAR, FF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (20) :7696-7700
[4]  
DISTLERATH LM, 1985, J BIOL CHEM, V260, P9057
[5]   The human cytosolic molecular chaperones hsp90, Hsp70 (hsc70) and hdj-1 have distinct roles in recognition of a non-native protein and protein refolding [J].
Freeman, BC ;
Morimoto, RI .
EMBO JOURNAL, 1996, 15 (12) :2969-2979
[6]   Expression of drug-metabolizing enzymes [J].
Guengerich, FP ;
Parikh, A .
CURRENT OPINION IN BIOTECHNOLOGY, 1997, 8 (05) :623-628
[7]  
Guengerich FP, 1995, CYTOCHROME P, P473
[8]   Role of the alanine at position 363 of cytochrome P450 2B2 in influencing the NADPH- and hydroperoxide-supported activities [J].
Hanna, IH ;
Teiber, JF ;
Kokones, KL ;
Hollenberg, PF .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1998, 350 (02) :324-332
[9]   Development of bacterial expression system with high yield of CYP3A7, a human fetus-specific form of cytochrome P450 [J].
Inoue, E ;
Takahashi, Y ;
Imai, Y ;
Kamataki, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 269 (02) :623-627
[10]   High catalytic activity of human cytochrome P450 co-expressed with human NADPH-cytochrome P450 reductase in Escherichia coli [J].
Iwata, H ;
Fujita, K ;
Kushida, H ;
Suzuki, A ;
Konno, Y ;
Nakamura, K ;
Fujino, A ;
Kamataki, T .
BIOCHEMICAL PHARMACOLOGY, 1998, 55 (08) :1315-1325